Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8
Frequently Asked Questions
What is Market Cap of Dermata Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dermata Therapeutics Inc market cap is $3.68M.
What is the 52-week high for Dermata Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dermata Therapeutics Inc 52 week high is $24.90 as of September 13, 2025.
What is the 52-week low for Dermata Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dermata Therapeutics Inc 52 week low is $5.04 as of September 13, 2025.
What is Dermata Therapeutics Inc stock price today?
Dermata Therapeutics Inc stock price today is $5.41.
What was Dermata Therapeutics Inc stock price yesterday?
Dermata Therapeutics Inc stock price yesterday was $5.40.
What is the PE ratio of Dermata Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dermata Therapeutics Inc’s P/E ratio is -0.14.
What is the Price-to-Book ratio of Dermata Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dermata Therapeutics Inc P/B ratio is 0.6134.
What is the 50-day moving average of Dermata Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dermata Therapeutics Inc 50-day moving average is $6.27.
How many employess does Dermata Therapeutics Inc has?